27778231|t|Identification of potential predictive markers of dexamethasone resistance in childhood acute lymphoblastic leukemia
27778231|a|Response to dexamethasone (DEXA), as a hallmark drug in the treatment of childhood acute lymphoblastic leukemia (ALL), is one of the pivotal prognostic factors in the prediction of outcome in ALL. Identification of predictive markers of chemoresistance is beneficial to selecting of the best therapeutic protocol with the lowest effect adverse. Hence, we aimed to find drug targets using the 2DE / MS proteomics study of a DEXA - resistant cell line (REH) as a model for poor DEXA responding patients before and after drug treatment. Using the proteomic methods, three differentially expressed proteins were detected, including voltage dependent anion channel 1 (VDAC1), sorting Nexin 3 (SNX3), and prefoldin subunit 6 (PFDN6). We observed low expression of three proteins after DEXA treatment in REH cells. We subsequently verified low expression of resulted proteins at the mRNA level using the quantitative PCR method. These proteins are promising proteins because of their important roles in drug resistance and regulation of apoptosis (VDAC1), protein trafficking (SNX3), and protein folding (PFDN6). Additionally, mRNA expression level of these proteins was assessed in 17 bone marrow samples from children with newly diagnosed ALL and 7 non-cancerous samples as controls. The results indicated that independent of the molecular subtypes of leukemia, mRNA expression of VDAC1, SNX3, and PFDN6 decreased in ALL samples compared with non-cancerous samples particularly in VDAC1 (p < 0.001). Additionally, mRNA expression of three proteins was also declined in high-risk samples compared with standard risk cases. These results demonstrated diagnostic and prognostic value of these proteins in childhood ALL. Furthermore, investigation of protein-protein interaction using STRING database indicated that these proteins involved in the signaling pathway of NR3C1 as dexamethasone target. In conclusion, our proteomic study in DEXA resistant leukemic cells revealed VDAC1, SNX3, and PFDN6 are promising proteins that might serve as potential biomarkers of prognosis and chemotherapy in childhood ALL.
27778231	50	63	dexamethasone	T103	UMLS:C0011777
27778231	64	74	resistance	T038	UMLS:C0013203
27778231	88	116	acute lymphoblastic leukemia	T038	UMLS:C0023449
27778231	117	125	Response	T038	UMLS:C0683154
27778231	129	142	dexamethasone	T103	UMLS:C0011777
27778231	144	148	DEXA	T103	UMLS:C0011777
27778231	156	169	hallmark drug	T103	UMLS:C1254351
27778231	200	228	acute lymphoblastic leukemia	T038	UMLS:C0023449
27778231	230	233	ALL	T038	UMLS:C0023449
27778231	258	276	prognostic factors	T201	UMLS:C1514474
27778231	284	305	prediction of outcome	T058	UMLS:C0033325
27778231	309	312	ALL	T038	UMLS:C0023449
27778231	354	369	chemoresistance	T038	UMLS:C0013203
27778231	409	429	therapeutic protocol	T058	UMLS:C0040808
27778231	446	460	effect adverse	T038	UMLS:C0879626
27778231	486	498	drug targets	T074	UMLS:C0085104
27778231	509	512	2DE	T058	UMLS:C0013860
27778231	515	517	MS	T058	UMLS:C0037813
27778231	518	534	proteomics study	T058	UMLS:C0022885
27778231	540	544	DEXA	T103	UMLS:C0011777
27778231	547	566	resistant cell line	T017	UMLS:C0007600
27778231	568	571	REH	T017	UMLS:C0007600
27778231	593	597	DEXA	T103	UMLS:C0011777
27778231	635	649	drug treatment	T058	UMLS:C0013216
27778231	661	678	proteomic methods	T058	UMLS:C0022885
27778231	701	710	expressed	T038	UMLS:C1171362
27778231	711	719	proteins	T103	UMLS:C0033684
27778231	725	733	detected	T033	UMLS:C0442726
27778231	745	778	voltage dependent anion channel 1	T103	UMLS:C0753015
27778231	780	785	VDAC1	T103	UMLS:C0753015
27778231	788	803	sorting Nexin 3	T103	UMLS:C1741224
27778231	805	809	SNX3	T103	UMLS:C1741224
27778231	816	835	prefoldin subunit 6	T103	UMLS:C1743484
27778231	837	842	PFDN6	T103	UMLS:C1743484
27778231	861	871	expression	T038	UMLS:C1171362
27778231	881	889	proteins	T103	UMLS:C0033684
27778231	896	900	DEXA	T103	UMLS:C0011777
27778231	914	923	REH cells	T017	UMLS:C0007600
27778231	954	964	expression	T038	UMLS:C1171362
27778231	977	985	proteins	T103	UMLS:C0033684
27778231	993	997	mRNA	T103	UMLS:C0035696
27778231	1014	1037	quantitative PCR method	T058	UMLS:C2733022
27778231	1045	1053	proteins	T103	UMLS:C0033684
27778231	1068	1076	proteins	T103	UMLS:C0033684
27778231	1113	1128	drug resistance	T038	UMLS:C0013203
27778231	1133	1156	regulation of apoptosis	T038	UMLS:C1148568
27778231	1158	1163	VDAC1	T103	UMLS:C0753015
27778231	1166	1185	protein trafficking	T038	UMLS:C0599895
27778231	1187	1191	SNX3	T103	UMLS:C1741224
27778231	1198	1213	protein folding	T038	UMLS:C0162847
27778231	1215	1220	PFDN6	T103	UMLS:C1743484
27778231	1237	1241	mRNA	T103	UMLS:C0035696
27778231	1268	1276	proteins	T103	UMLS:C0033684
27778231	1296	1315	bone marrow samples	T031	UMLS:C0438737
27778231	1351	1354	ALL	T038	UMLS:C0023449
27778231	1442	1460	molecular subtypes	T170	UMLS:C0449560
27778231	1464	1472	leukemia	T038	UMLS:C0023418
27778231	1474	1478	mRNA	T103	UMLS:C0035696
27778231	1479	1489	expression	T038	UMLS:C1171362
27778231	1493	1498	VDAC1	T103	UMLS:C0753015
27778231	1500	1504	SNX3	T103	UMLS:C1741224
27778231	1510	1515	PFDN6	T103	UMLS:C1743484
27778231	1529	1532	ALL	T038	UMLS:C0023449
27778231	1593	1598	VDAC1	T103	UMLS:C0753015
27778231	1626	1630	mRNA	T103	UMLS:C0035696
27778231	1631	1641	expression	T038	UMLS:C1171362
27778231	1651	1659	proteins	T103	UMLS:C0033684
27778231	1681	1690	high-risk	T033	UMLS:C0332167
27778231	1776	1786	prognostic	T170	UMLS:C0220901
27778231	1802	1810	proteins	T103	UMLS:C0033684
27778231	1824	1827	ALL	T038	UMLS:C0023449
27778231	1842	1855	investigation	T058	UMLS:C0220825
27778231	1859	1886	protein-protein interaction	T038	UMLS:C0872079
27778231	1893	1899	STRING	T170	UMLS:C1547402
27778231	1900	1908	database	T170	UMLS:C0242356
27778231	1930	1938	proteins	T103	UMLS:C0033684
27778231	1955	1972	signaling pathway	T038	UMLS:C0037080
27778231	1976	1981	NR3C1	T103	UMLS:C1370369
27778231	1985	1998	dexamethasone	T103	UMLS:C0011777
27778231	1999	2005	target	T033	UMLS:C0243095
27778231	2026	2041	proteomic study	T058	UMLS:C0022885
27778231	2045	2049	DEXA	T103	UMLS:C0011777
27778231	2050	2059	resistant	T038	UMLS:C0013203
27778231	2060	2074	leukemic cells	T017	UMLS:C1517806
27778231	2084	2089	VDAC1	T103	UMLS:C0753015
27778231	2091	2095	SNX3	T103	UMLS:C1741224
27778231	2101	2106	PFDN6	T103	UMLS:C1743484
27778231	2121	2129	proteins	T103	UMLS:C0033684
27778231	2160	2170	biomarkers	T201	UMLS:C0005516
27778231	2174	2183	prognosis	T058	UMLS:C0033325
27778231	2188	2200	chemotherapy	T058	UMLS:C3665472
27778231	2214	2217	ALL	T038	UMLS:C0023449